Novo Nordisk’s CagriSema outperforms Ozempic in Phase III trial
- Posted on February 3, 2026
- By Yahoo News
- 4 Views
Novo Nordisk’s CagriSema outperforms Ozempic in Phase III trial
While the drug also previously succeeded in two obesity studies, it fell short of expectations at the time.
